Record Status This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database. Citation Institut für Qualität und Wirtschaftlichkeit im Gesundheitswesen. Opicapon (Parkinsonkrankheit): Addendum zum Auftrag A16-61; Auftrag A17-04. [Opicapone (Parkinson disease): Addendum to Commission A16-61] Cologne: Institut fuer Qualitaet und Wirtschaftlichkeit im Gesundheitswesen (IQWiG). IQWiG-Berichte 489. 2017 Indexing Status Subject indexing assigned by CRD MeSH Antiparkinson Agents; Humans; Oxadiazoles; Parkinson Disease Country of organisation Germany English summary There is no English language summary available. Address for correspondence IQWiG, Im Mediapark 8, DE-50670 Cologne, GERMANY, Tel: +49 (0) 221 - 35685 - 0, Fax: +49 (0) 221 - 35685 - 1 Email: berichte@iqwig.de AccessionNumber 32017000230 Date abstract record published 24/04/2017 |